Past Lecture
Tick Related Infections Seen
in Connecticut
With James Sabetta, MD

Our well-attended Women's Heart lecture, held February 8, 2017, featured Dr. James Sabetta, Director of Infectious Diseases and Internal Medicine at Greenwich Hospital.

Lyme disease is the most common of the tick-borne diseases, but it's not the only one. In Connecticut, anaplasmosis and babesiosis infections are also being reported. At our well-attended Women's Health Initiative lecture, Dr. Sabetta explained that we are basically "living in the woods" in Connecticut where ticks are plentiful. Depending on the location, anywhere from less than 1% to more than 50% of ticks are infected with Lyme disease. A bite from a tick infected with Lyme disease bacteria (Borrelia burgdorferi) can put a person at risk for Lyme disease.

Common symptoms of Lyme disease are:

  • A rash (that can be small at first and then grown into a large, well defined oval, or bulls-eye)
  • Headache
  • Stiff neck
  • Aches and pains in muscles and joints
  • Low grade fever and chills
  • Fatigue

To learn more about Lyme Disease, visit the Health Library on Greenwich Hospital's website:


Lecture Series


Women's Health Intiative

Donald Max Engelman, PhD
Stimulating talk 
Held May 2, 2017 at Greenwich Hospital

Tumor Acidity: A new approach to targeting breast and other tumors

Speaker: Donald Max Engelman, PhD
Higgins Professor of Molecular Biophysics and Biochemistry, Yale University

Tumors are acidic, and the more aggressive a tumor is, the more acidic it is. Dr. Engelman and his team have developed new ways to take advantage of tumor acidity as a target for diagnosis and therapy. Despite advances in early detection and understanding of the molecular bases of breast cancer biology, approximately 30% of all patients with early-stage breast cancer have recurrent disease, which is metastatic in most cases. Acidity may be a better target than markers used in other approaches that often fail through the emergence of resistant tumors.

Dr. Engelman, accompanied by John Deacon, PhD, associate research scientist, explained that normal cells and cancer cells have about the same amount of acidity inside them. It is the pH outside the cancer cell that has greater acidity. Dr. Engelman and his team have discovered a useful peptide (a molecule consisting of 2 or more amino acids) called pH (Low) Insertion Peptide, or pHLIP. This pH-sensitive peptide is sensitive enough to detect small pH differences and will prove useful in finding solid acidic tumors with high accuracy. The pHLIP technology will pave the way to detect, target and treat acidic diseased tissue by employing the selective insertion and folding of membrane peptides.

Sponsored by the
Greenwich Hospital Women's Health Initiative

Advisory Board: Shelley H. Behrman, Chairman; Missy Baschkin; Jane M. Batkin; Karen Brown; Susan H. Brown; Serena Flaherty; Pamela M. Goergen; Mary A. Jacobson; Anne Juge; Louise Kovacs; Shelley Tretter Lynch; Susan Z. Mandel; Barbara B. Miller; Barbara Netter; Mini Nunna; Sharon Phillips; Carol M. Santora; Carol Swift; Katherine Vadasdi, MD


Save the Date: 2017 Fundraising Events




Under the Stars
June 24, 2017

An evening under the stars.
A benefit for Women's and Children's Health at Greenwich Hospital.
This year's event featured a performance by GRAMMY® nominated, multi-platinum selling singer songwriter Gavin DeGraw. 






Glow Gala
October 21, 2017

The 2017 Gala for Greenwich Hospital.



Celebrations & Lectures

Women's Health Initiative
May 2, 2017
Tumor Acidity: A new approach to targeting breast and other tumors
Speaker: Donald Max Engelman, PhD
Higgins Professor of Molecular Biophysics and Biochemistry, Yale University